Ramona C. Dolscheid-Pommerich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ramona C. Dolscheid-Pommerich has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Birgit Stoffel-Wagner
7 shared publications- Lars Eichhorn
Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, 53127 Bonn, Germany
4 shared publications Berndt Zur
Department of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany
2 shared publications- Berndt Zur
Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinik Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Deutschland.
2 shared publications Ingo Graeff
2 shared publications- Rupert Conrad
Department of Psychosomatic Medicine and Psychotherapy, University of Bonn, Bonn, Germany
2 shared publications
Latest Publications
- Open Access
- 22 February 2018
- Published by Ommega Online Publishers in Journal of Anesthesia and Surgery
- Vol. 5 (1) , 22-40
Retrospective evaluation of the accuracy of Point of Care versus central laboratory sodium measurements at a supra maximal care hospital
Background: Sodium is most frequently requested by the emergency department (ED). It can be measured by direct or indirect ion-selective electrodes (ISE). Aim: Comparison of sodium values obtained from POCT under proven concept conditions and Central Laboratory (CL) analyzers in an accredited laboratory in a large collective of patients. Do significant differences exist in sodium values obtained by direct/indirect ISE?Methods: In 1941 patients, sodium values were established with POCT-blood gas analyzers in parallel with CL-analyzers. Differences between values were calculated. Clinical relevant outliers were evaluated according to reference and alarm ranges. Data were analyzed with correlation analysis, Bland-Altman plot and outlier evaluation.Results: Average age was 55.7 years. Male-to-female ratio was 1149:792. Mean value of the absolute difference between POCT and CL sodium was 0.9 mmol/l. POCT sodium mean value was 137.9 mmol/l (SD 4.7) and CL sodium mean value was 139.6 mmol/l (SD 4.2). POCT sodium and CL sodium correlated significantly (r = 0.81, p < 0.0001). Bland-Altman´s mean difference of the measurement values was 1.6 (limits of agreement -3.8 to +7.1). 433 patients had sodium values outside of reference ranges. In 197, both values resulted in the same diagnosis. McNemar´s test revealed significant differences (p < 0.0001). 9 patients had values outside alarm ranges, in five of these cases, both values resulted in the same diagnosis.Conclusion: We showed that in a large ED-collective of a supra maximal care hospital more than 85% of the patients had no clinically relevant discrepancies regarding their sodium values obtained with direct or indirect ISE.
- 22 February 2018
- Published by Ommega Online Publishers in Journal of Anesthesia and Surgery
- Vol. 5 (1) , 22-40
Open AccessRetrospective evaluation of the accuracy of Point of Care versus central laboratory sodium measurements at a supra maximal care hospital
Background: Sodium is most frequently requested by the emergency department (ED). It can be measured by direct or indirect ion-selective electrodes (ISE). Aim: Comparison of sodium values obtained from POCT under proven concept conditions and Central Laboratory (CL) analyzers in an accredited laboratory in a large collective of patients. Do significant differences exist in sodium values obtained by direct/indirect ISE?Methods: In 1941 patients, sodium values were established with POCT-blood gas analyzers in parallel with CL-analyzers. Differences between values were calculated. Clinical relevant outliers were evaluated according to reference and alarm ranges. Data were analyzed with correlation analysis, Bland-Altman plot and outlier evaluation.Results: Average age was 55.7 years. Male-to-female ratio was 1149:792. Mean value of the absolute difference between POCT and CL sodium was 0.9 mmol/l. POCT sodium mean value was 137.9 mmol/l (SD 4.7) and CL sodium mean value was 139.6 mmol/l (SD 4.2). POCT sodium and CL sodium correlated significantly (r = 0.81, p < 0.0001). Bland-Altman´s mean difference of the measurement values was 1.6 (limits of agreement -3.8 to +7.1). 433 patients had sodium values outside of reference ranges. In 197, both values resulted in the same diagnosis. McNemar´s test revealed significant differences (p < 0.0001). 9 patients had values outside alarm ranges, in five of these cases, both values resulted in the same diagnosis.Conclusion: We showed that in a large ED-collective of a supra maximal care hospital more than 85% of the patients had no clinically relevant discrepancies regarding their sodium values obtained with direct or indirect ISE.
- Open Access
- 31 January 2017
- Published by Walter de Gruyter GmbH in Journal of Laboratory Medicine
- Vol. 41 (1) , 3-11
Method comparison of tumor markers assessed by LOCI™- and ECLIA-based technologies
Background: Since the introduction of luminescent oxygen channeling immunoassays (LOCI™)-based assays in the daily laboratory routine of tumor marker measurements, only a small number of method comparisons with established immunoassays have been published. We performed a method comparison between LOCI™-based tumor marker assays for Dimension™ VISTA and electrochemiluminiscent immunoassays (ECLIA) for Cobas™ e411, for α-fetoprotein (AFP), carcinoembryonic antigen (CEA), CA 125, CA 15-3, CA 19-9, prostate-specific antigen (PSA) and free PSA (fPSA). Methods: Tumor markers were assessed in 1088 sera from routine diagnostics on the Dimension™ VISTA 1500 and Cobas™ e411 analyzers. Results: Strong correlations were achieved for PSA (r=0.999), AFP (r=0.994) and CEA (r=0.993). Results were quite comparable as only minor slopes of 1.05 (PSA), 1.02 (AFP) and 0.94 (CEA), respectively, were found. However, correlations for CA 125 (r=0.976), CA 19-9 (r=0.960), fPSA (r=0.950) and CA 15-3 (r=0.940) were only moderate, and considerable slopes were observed for these markers with higher values for CA 19-9 (slope 1.50) and lower ones for CA 15-3 (0.76), fPSA (0.75) and CA 125 (0.64), for Dimension™ VISTA 1500. Conclusions: We found excellent correlations and comparable values for AFP, CEA and PSA, but only moderate correlations for fPSA, CA 125, CA 15-3 and CA 19-9. The slopes for CA 19-9, CA 15-3, fPSA and CA 125 have to be considered when analysis methods for tumor markers are changed.
- 31 January 2017
- Published by Walter de Gruyter GmbH in Journal of Laboratory Medicine
- Vol. 41 (1) , 3-11
Open AccessMethod comparison of tumor markers assessed by LOCI™- and ECLIA-based technologies
Background: Since the introduction of luminescent oxygen channeling immunoassays (LOCI™)-based assays in the daily laboratory routine of tumor marker measurements, only a small number of method comparisons with established immunoassays have been published. We performed a method comparison between LOCI™-based tumor marker assays for Dimension™ VISTA and electrochemiluminiscent immunoassays (ECLIA) for Cobas™ e411, for α-fetoprotein (AFP), carcinoembryonic antigen (CEA), CA 125, CA 15-3, CA 19-9, prostate-specific antigen (PSA) and free PSA (fPSA). Methods: Tumor markers were assessed in 1088 sera from routine diagnostics on the Dimension™ VISTA 1500 and Cobas™ e411 analyzers. Results: Strong correlations were achieved for PSA (r=0.999), AFP (r=0.994) and CEA (r=0.993). Results were quite comparable as only minor slopes of 1.05 (PSA), 1.02 (AFP) and 0.94 (CEA), respectively, were found. However, correlations for CA 125 (r=0.976), CA 19-9 (r=0.960), fPSA (r=0.950) and CA 15-3 (r=0.940) were only moderate, and considerable slopes were observed for these markers with higher values for CA 19-9 (slope 1.50) and lower ones for CA 15-3 (0.76), fPSA (0.75) and CA 125 (0.64), for Dimension™ VISTA 1500. Conclusions: We found excellent correlations and comparable values for AFP, CEA and PSA, but only moderate correlations for fPSA, CA 125, CA 15-3 and CA 19-9. The slopes for CA 19-9, CA 15-3, fPSA and CA 125 have to be considered when analysis methods for tumor markers are changed.
- Open Access
- 23 November 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (11) , e0166521
Comparability of Point-of-Care versus Central Laboratory Hemoglobin Determination in Emergency Patients at a Supra-Maximal Care Hospital
Fulfilling the requirements of point-of-care testing (POCT) training regarding proper execution of measurements and compliance with internal and external quality control specifications is a great challenge. Our aim was to compare the values of the highly critical parameter hemoglobin (Hb) determined with POCT devices and central laboratory analyzer in the highly vulnerable setting of an emergency department in a supra maximal care hospital to assess the quality of POCT performance. In 2548 patients, Hb measurements using POCT devices (POCT-Hb) were compared with Hb measurements performed at the central laboratory (Hb-ZL). Additionally, sub collectives (WHO anemia classification, patients with Hb 85y.) were analyzed. Overall, the correlation between POCT-Hb and Hb-ZL was highly significant (r = 0.96, pt(2547) = 36.1, p2.5g/dl occurred. McNemar´s test revealed significant differences regarding anemia diagnosis according to WHO definition for male, female and total patients (♂ pppp = 0.169). In suprageriatric patients, McNemar´s test revealed significant differences regarding anemia diagnosis according to WHO definition in male, female and total patients (♂ pp = 0.002, total pp = 1.000). Overall, we found a highly significant correlation between the analyzed hemoglobin concentration measurement methods, i.e. POCT devices and at the central laboratory. The results confirm the successful implementation of the presented POCT concept. Nevertheless some limitations could be identified in anemic patients stressing the importance of carefully examining clinically implausible results.
- 23 November 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (11) , e0166521
Open AccessComparability of Point-of-Care versus Central Laboratory Hemoglobin Determination in Emergency Patients at a Supra-Maximal Care Hospital
Fulfilling the requirements of point-of-care testing (POCT) training regarding proper execution of measurements and compliance with internal and external quality control specifications is a great challenge. Our aim was to compare the values of the highly critical parameter hemoglobin (Hb) determined with POCT devices and central laboratory analyzer in the highly vulnerable setting of an emergency department in a supra maximal care hospital to assess the quality of POCT performance. In 2548 patients, Hb measurements using POCT devices (POCT-Hb) were compared with Hb measurements performed at the central laboratory (Hb-ZL). Additionally, sub collectives (WHO anemia classification, patients with Hb 85y.) were analyzed. Overall, the correlation between POCT-Hb and Hb-ZL was highly significant (r = 0.96, pt(2547) = 36.1, p2.5g/dl occurred. McNemar´s test revealed significant differences regarding anemia diagnosis according to WHO definition for male, female and total patients (♂ pppp = 0.169). In suprageriatric patients, McNemar´s test revealed significant differences regarding anemia diagnosis according to WHO definition in male, female and total patients (♂ pp = 0.002, total pp = 1.000). Overall, we found a highly significant correlation between the analyzed hemoglobin concentration measurement methods, i.e. POCT devices and at the central laboratory. The results confirm the successful implementation of the presented POCT concept. Nevertheless some limitations could be identified in anemic patients stressing the importance of carefully examining clinically implausible results.
- 23 September 2016
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 113 (38) , 642-643
Genetic Factors
Parhofer in his article explains that the lipoprotein(a) concentration is mostly genetically determined. Furthermore, he recommends that it needs to be measured only once, with a second measurement for confirmation if required (1). Although the...
- 23 September 2016
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 113 (38) , 642-643
Genetic Factors
Parhofer in his article explains that the lipoprotein(a) concentration is mostly genetically determined. Furthermore, he recommends that it needs to be measured only once, with a second measurement for confirmation if required (1). Although the...
- Open Access
- 1 January 2016
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 26 (1) , 82-89
Evaluation of the appropriate time period between sampling and analyzing for automated urinalysis
Evaluation of the appropriate time period between sampling and analyzing for automated urinalysis
- 1 January 2016
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 26 (1) , 82-89
Open AccessEvaluation of the appropriate time period between sampling and analyzing for automated urinalysis
Evaluation of the appropriate time period between sampling and analyzing for automated urinalysis
- 1 April 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 444, 167-169
IgG subclass distribution in patients with monoclonal gammopathy
- 1 April 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 444, 167-169
IgG subclass distribution in patients with monoclonal gammopathy
- 1 April 2015
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 108 (1) , 15-22
Impact of carbamylation on three different methods, HPLC, capillary electrophoresis and TINIA of measuring HbA1c levels in patients with kidney disease
- 1 April 2015
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 108 (1) , 15-22
Impact of carbamylation on three different methods, HPLC, capillary electrophoresis and TINIA of measuring HbA1c levels in patients with kidney disease